A revolution in the treatment of non-Hodgkin's lymphoma.
The use of monoclonal antibodies (MoAbs) for immunotherapy and radioimmunotherapy has ushered in a new era in the treatment of non-Hodgkin's lymphoma.
DeNardo
G L
GL
University of California, Davis, School of Medicine, Department of Internal Medicine, Sacramento 95618, USA.
O'Donnell
R T
RT
Oldham
R K
RK
DeNardo
S J
SJ
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D016499:Radioimmunotherapy
D000911:Antibodies, Monoclonal